Adria Merino-Tort

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications

Neuropsychological Profile and Cognitive Trajectories of Patients With Biomarker Evidence of Alzheimer Disease or Dementia With Lewy bodies.

Neuropsychological Profile and Cognitive Trajectories of Patients With Biomarker Evidence of Alzheimer Disease or Dementia With Lewy bodies.

Journal: Neurology
Published: July 01, 2026

Impact of a multimodal prehabilitation program on postoperative cognitive dysfunction: a single-center randomized controlled trial.

Impact of a multimodal prehabilitation program on postoperative cognitive dysfunction: a single-center randomized controlled trial.

Journal: Journal of clinical anesthesia
Published: May 20, 2026

Atrophy signature for alpha-synuclein copathology in Alzheimer's disease.

Atrophy signature for alpha-synuclein copathology in Alzheimer's disease.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: January 26, 2026

Predictive Ability of Plasma p-tau217 for β-Amyloid Status: A Prospective Multicenter Study.

Predictive Ability of Plasma p-tau217 for β-Amyloid Status: A Prospective Multicenter Study.

Journal: Annals of clinical and translational neurology
Published: January 26, 2026

Proteomic analysis in Alzheimer's disease and other dementias: a focus on sex-specific differences.

Proteomic analysis in Alzheimer's disease and other dementias: a focus on sex-specific differences.

Journal: Alzheimer's research & therapy
Published: January 20, 2026

Practice effects as a dynamic biomarker of early cognitive change in far-from-onset Huntington's disease.

Practice effects as a dynamic biomarker of early cognitive change in far-from-onset Huntington's disease.

Journal: Brain communications
Published: December 01, 2025

Relationship between locus coeruleus and slow-wave sleep in aging and Alzheimer's disease.

Relationship between locus coeruleus and slow-wave sleep in aging and Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: November 17, 2025

Plasma p-Tau217 and GFAP predict widespread cognitive decline in Alzheimer's disease.

Plasma p-Tau217 and GFAP predict widespread cognitive decline in Alzheimer's disease.

Journal: Journal of neurology
Published: October 09, 2025

Amyloid-negative neuropsychological norms: Added value in the era of biomarkers and disease-modifying therapies.

Amyloid-negative neuropsychological norms: Added value in the era of biomarkers and disease-modifying therapies.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: September 11, 2025

α-Synuclein Seed Amplifications Assay in a Cohort With Cognitive Impairment: Performance and Interactions With CSF and Plasma Biomarkers.

α-Synuclein Seed Amplifications Assay in a Cohort With Cognitive Impairment: Performance and Interactions With CSF and Plasma Biomarkers.

Journal: Neurology
Published: September 08, 2025

Cortical asymmetry in autosomal dominant Alzheimer's disease progression.

Cortical asymmetry in autosomal dominant Alzheimer's disease progression.

Journal: Brain communications
Published: June 24, 2025

Mitochondrial methylcytosines as blood-based biomarkers for Alzheimer's disease dementia prognosis.

Mitochondrial methylcytosines as blood-based biomarkers for Alzheimer's disease dementia prognosis.

Journal: iScience
Published: April 09, 2025
Showing 1-12 of 47

Last Updated: 09/26/2026